蓝箭航天，科创板IPO获受理

Core Viewpoint - Blue Arrow Aerospace has received approval for its IPO application on the Shanghai Stock Exchange, aiming to raise 7.5 billion yuan, shortly after the exchange's new guidelines for commercial rocket companies were released [1][2]. Company Summary - Blue Arrow Aerospace is a leading commercial aerospace company in China, focusing on the research, production, and launch services of liquid oxygen-methane engines and rockets. The company aims to establish a full industry chain centered around medium to large reusable liquid oxygen-methane launch vehicles [2]. - The company's revenue from 2022 to 2024 was 780,000 yuan, 3.95 million yuan, and 4.28 million yuan, respectively, with net losses of 800 million yuan, 1.188 billion yuan, and 876 million yuan. In the first half of 2025, the company reported revenue of 36.43 million yuan and a net loss of 597 million yuan [2]. - The Zhuque-2 series medium liquid oxygen-methane rocket has entered mass production and commercial use, while the Zhuque-3 medium to large reusable rocket is set to make its maiden flight on December 3, 2025, marking China's first attempt at first-stage recovery [2]. Industry Summary - Since June 2025, the capital market for commercial aerospace has accelerated, with several companies, including Blue Arrow Aerospace, preparing to enter the market. The A-share commercial aerospace sector has seen a significant increase, with the index rising by 52.32% as of December 31, 2025 [4]. - The industry is experiencing a rapid capitalizing process, driven by breakthroughs in reusable rocket technology and an increase in low-orbit satellite launches, which are facilitating a more frequent and normalized launch schedule [4]. - By the end of 2025, several new commercial rocket models are expected to have their maiden flights or recovery tests, potentially leading to a transformative phase in China's rocket recovery era in 2026 [4].